Bioinformatic analysis of CRISPR/Cas system in Lactobacillus jensenii

  • HU Qi ,
  • LIAO Caiyu ,
  • TANG Jiachen ,
  • TANG Ke ,
  • CHENG Daomei ,
  • ZHAO Changsong ,
  • YU Meiyan ,
  • HAN Yunlei
Expand
  • 1(School of Public Health, Chengdu Medical College, Chengdu 610500, China)
    2(School of Health and Intelligent Engineering, Chengdu Medical College, Chengdu 610500, China)
    3(School of Basic Medical Sciences, Chengdu Medical College, Chengdu 610500, China)

Received date: 2025-07-14

  Revised date: 2025-09-28

  Online published: 2026-06-03

Abstract

Clustered regularly interspaced short palindromic repeats (CRISPR) and associated proteins (Cas) have been widely applied in genome editing and molecular diagnostics.To develop genome editing tools based on the Lactobacillus jensenii CRISPR/Cas system, this study performed a bioinformatic analysis of its structural features and potential mechanisms of action. A total of 177 L.jensenii genomes from the GenBank database were analyzed.Using CRISPRViz to identify CRISPR loci.CRISPROne predicted Cas protein types and tracrRNA positions.MEGA X was employed to construct phylogenetic trees.RNAfold analyzed the secondary structures of repeat sequences.CRISPRTarget performed spacer homology analysis and protospacer adjacent motif (PAM) prediction.Among the 177 genomes, 146 (82.49%) contained CRISPR loci, comprising 152 confirmed arrays.The CRISPR repeats ranged from 27 to 40 nucleotides, while spacer ranged from 28 to 40 nucleotides, with 3 to 44 spacers per array.A total of 144 strains carried cas9 genes, predominantly of partial subtype Ⅱ-A (128 strains, 88.89%), and subtype Ⅱ-A genes were detected in 15 strains (10.42%).One strain harbored cas genes from both subtypes.Additionally, 86 strains contained one tracrRNA gene, located in the non-coding region between cas1 and cas9 genes.Of the 769 unique spacers, 219 targeted phages, 59 targeted plasmids, and the remainder had unknown targets.The predicted PAM sequence recognized by L.jensenii Cas9 was 5′-CCA-3′.These findings provide a reference for developing CRISPR/Cas9-based gene editing tools for L.jensenii.

Cite this article

HU Qi , LIAO Caiyu , TANG Jiachen , TANG Ke , CHENG Daomei , ZHAO Changsong , YU Meiyan , HAN Yunlei . Bioinformatic analysis of CRISPR/Cas system in Lactobacillus jensenii[J]. Food and Fermentation Industries, 2026 , 52(9) : 1 -9 . DOI: 10.13995/j.cnki.11-1802/ts.043897

References

[1] STERN A, MICK E, TIROSH I, et al.CRISPR targeting reveals a reservoir of common phages associated with the human gut microbiome[J].Genome Research, 2012, 22(10):1985-1994.
[2] ZHANG Q, YE Y Z.Not all predicted CRISPR-Cas systems are equal:Isolated cas genes and classes of CRISPR like elements[J].BMC Bioinformatics, 2017, 18(1):92.
[3] KARVELIS T, GASIUNAS G, MIKSYS A, et al.crRNA and tracrRNA guide Cas9-mediated DNA interference in Streptococcus thermophilus[J].RNA Biology, 2013, 10(5):841-851.
[4] LIU G W, LIN Q P, JIN S, et al.The CRISPR-Cas toolbox and gene editing technologies[J].Molecular Cell, 2022, 82(2):333-347.
[5] LI T X, YANG Y Y, QI H Z, et al.CRISPR/Cas9 therapeutics:Progress and prospects[J].Signal Transduction and Targeted Therapy, 2023, 8:36.
[6] HUANG J, ZHOU Y T, LI J, et al.CRISPR/Cas systems:Delivery and application in gene therapy[J].Frontiers in Bioengineering and Biotechnology, 2022, 10:942325.
[7] MEI Z J, LI D D.The role of probiotics in vaginal health[J].Frontiers in Cellular and Infection Microbiology, 2022, 12:963868.
[8] CHEE W J Y, CHEW S Y, THAN L T L.Vaginal microbiota and the potential of Lactobacillus derivatives in maintaining vaginal health[J].Microbial Cell Factories, 2020, 19(1):203.
[9] ANGLENIUS H, MÄKIVUOKKO H, AHONEN I, et al.In vitro screen of Lactobacilli strains for gastrointestinal and vaginal benefits[J].Microorganisms, 2023, 11(2):329.
[10] LI C X, PENG K X, XIAO S Q, et al.The role of Lactobacillus in inflammatory bowel disease:From actualities to prospects[J].Cell Death Discovery, 2023, 9:361.
[11] GARNEAU J E, MOINEAU S.Bacteriophages of lactic acid bacteria and their impact on milk fermentations[J].Microbial Cell Factories, 2011, 10(Suppl 1):S20.
[12] PUTONTI C, AHMAD A, BADDOO G, et al.Draft genome sequences of 11 Lactobacillus jensenii strains isolated from the female bladder[J].Microbiology Resource Announcements, 2019, 8(35)
[13] CRAWLEY A B, HENRIKSEN E D, STOUT E, et al.Characterizing the activity of abundant, diverse and active CRISPR-Cas systems in Lactobacilli[J].Scientific Reports, 2018, 8:11544.
[14] CHYLINSKI K, LE RHUN A, CHARPENTIER E. The tracrRNA and Cas9 families of type II CRISPR-Cas immunity systems[J]. RNA Biology, 2013, 10(5): 726-737.
[15] YANG L, LI W X, UJIROGHENE O J, et al.Occurrence and diversity of CRISPR loci in Lactobacillus casei group[J].Frontiers in Microbiology, 2020, 11:624.
[16] ALKHNASHI O S, SHAH S A, GARRETT R A, et al. Characterizing leader sequences of CRISPR loci[J]. Bioinformatics, 2016, 32(17): i576-i585.
[17] SANTIAGO-FRANGOS A, BUYUKYORUK M, WIEGAND T, et al.Distribution and phasing of sequence motifs that facilitate CRISPR adaptation[J].Current Biology, 2021, 31(16):3515-3524.e6.
[18] CHYOU T Y, BROWN C M.Prediction and diversity of tracrRNAs from type II CRISPR-Cas systems[J].RNA Biology, 2019, 16(4):423-434.
[19] WANG Y, MAO T T, LI Y X, et al.Characterization of 67 confirmed clustered regularly interspaced short palindromic repeats loci in 52 strains of staphylococci[J].Frontiers in Microbiology, 2021, 12:736565.
[20] LONG J Z, XU Y K, OU L Y, et al.Diversity of CRISPR/cas system in Clostridium perfringens[J].Molecular Genetics and Genomics, 2019, 294(5):1263-1275.
[21] JINEK M, CHYLINSKI K, FONFARA I, et al.A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity[J].Science, 2012, 337(6096):816-821.
[22] ROSTAMPOUR M, PANAHI B, MASOUMI JAHANDIZI R.The CRISPR-Cas system in Lactiplantibacillus plantarum strains:Identification and characterization using a genome mining approach[J].Frontiers in Microbiology, 2024, 15:1394756.
[23] KIM J G, GARRETT S, WEI Y Z, et al.CRISPR DNA elements controlling site-specific spacer integration and proper repeat length by a Type II CRISPR-Cas system[J].Nucleic Acids Research, 2019, 47(16):8632-8648.
[24] MILLER-ENSMINGER T, MORMANDO R, MASKERI L, et al.Introducing Lu-1, a novel Lactobacillus jensenii phage abundant in the urogenital tract[J].PLoS One, 2020, 15(6):e0234159.
[25] MAKAROVA K S, WOLF Y I, IRANZO J, et al.Evolutionary classification of CRISPR-Cas systems:A burst of class 2 and derived variants[J].Nature Reviews Microbiology, 2020, 18(2):67-83.
[26] HAN X, ZHOU X Y, PEI Z M, et al.Characterization of CRISPR-cas systems in Bifidobacterium breve[J].Microbial Genomics, 2022, 8(4):000812.
[27] KUNIN V, SOREK R, HUGENHOLTZ P.Evolutionary conservation of sequence and secondary structures in CRISPR repeats[J].Genome Biology, 2007, 8(4):R61.
[28] WILKINSON M, DRABAVICIUS G, SILANSKAS A, et al.Structure of the DNA-bound spacer capture complex of a type II CRISPR-cas system[J].Molecular Cell, 2019, 75(1):90-101.e5.
[29] JAKHANWAL S, CRESS B F, MAGUIN P, et al.A CRISPR-Cas9-integrase complex generates precise DNA fragments for genome integration[J].Nucleic Acids Research, 2021, 49(6):3546-3556.
[30] LIAO C Y, BEISEL C L.The tracrRNA in CRISPR biology and technologies[J].Annual Review of Genetics, 2021, 55:161-181.
[31] GONÇALVES O S, CAMPOS K F, DE ASSIS J C S, et al.Transposable elements contribute to the genome plasticity of Ralstonia solanacearum species complex[J].Microbial Genomics, 2020, 6(5):e000374.
[32] DOOLEY S K, BAKEN E K, MOSS W N, et al.Identification and evolution of Cas9 tracrRNAs[J].The CRISPR Journal, 2021, 4(3):438-447.
[33] CHYLINSKI K, LE RHUN A, CHARPENTIER E.The tracrRNA and Cas9 families of type II CRISPR-Cas immunity systems[J].RNA Biology, 2013, 10(5):726-737.
[34] DELTCHEVA E, CHYLINSKI K, SHARMA C M, et al.CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III[J].Nature, 2011, 471(7340):602-607.
[35] COCOMAZZI G, DE STEFANI S, DEL PUP L, et al.The impact of the female genital microbiota on the outcome of assisted reproduction treatments[J].Microorganisms, 2023, 11(6):1443.
[36] MARTÍN R, ESCOBEDO S, SUÁREZ J E.Induction, structural characterization, and genome sequence of Lv1, a prophage from a human vaginal Lactobacillus jensenii strain[J].International Microbiology, 2010, 13(3):113-121.
[37] GLOBYTE V, LEE S H, BAE T, et al.CRISPR/Cas9 searches for a protospacer adjacent motif by lateral diffusion[J].The EMBO Journal, 2018, 38(4):EMBJ201899466.
[38] BERNAL-BERNAL D, ABELLÓN-RUIZ J, INIESTA A A, et al.Multifactorial control of the expression of a CRISPR-Cas system by an extracytoplasmic function σ/anti-σ pair and a global regulatory complex[J].Nucleic Acids Research, 2018, 46(13):6726-6745.
[39] LEE S, YOU H J, KWON B, et al.Complete genome sequence of Lactobacillus jensenii strain SNUV360, a probiotic for treatment of bacterial vaginosis isolated from the vagina of a healthy Korean woman[J].Genome Announcements, 2017, 5(10):e01757-16.
[40] ZAKRZEWSKA M, BURMISTRZ M.Mechanisms regulating the CRISPR-cas systems[J].Frontiers in Microbiology, 2023, 14:1060337.
Outlines

/

〈 〉